Tokai Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Tokai Pharmaceuticals Inc
TickerELDN
CIK #0001404281
CUSIP28617K101
SectorLife Sciences - Pharmaceutical Preparations
Address1 Broadway 14th Floor, Cambridge, MA 02142
Source [EDGAR]
CIK Filing 2011 - 2025
[0001404281] 10-K
[0001404281] 10-Q
[0001404281] 3
[0001404281] 4
[0001404281] 8-K
[0001404281] D
[0001404281] SC 13D
[0001404281] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Eledon Pharmaceuticals Inc [2025-07-29] 0.0
BlackRock Inc Eledon Pharmaceuticals Inc [2025-07-17] 0.0
RA Capital Management LP Eledon Pharmaceuticals Inc [2024-11-05] 6.1
Frazier Life Sciences Public Fund LP Eledon Pharmaceuticals Inc [2024-11-05] 81944.6
Armistice Capital LLC Eledon Pharmaceuticals Inc [2024-02-14] 0.99
Woodline Partners LP Eledon Pharmaceuticals Inc [2021-02-16] 5.4
FMR LLC Eledon Pharmaceuticals Inc [2021-02-08] 0.0
Adage Capital Partners GP LLC Eledon Pharmaceuticals Inc [2021-01-04] 5.89
Cormorant Asset Management LP Eledon Pharmaceuticals Inc [2021-01-04] 9.89
Logos Global Management LP Novus Therapeutics Inc [2020-11-09] 15.7
683 Capital Management LLC Novus Therapeutics Inc [2019-07-26] 8.8
Armistice Capital LLC Novus Therapeutics Inc [2019-06-05] 4.99
Biotechnology Value Fund L P Novus Therapeutics Inc [2019-05-10] 6.1
Lifesci Index Partners LLC Novus Therapeutics Inc [2018-03-13] 5.31
Nussbaum Ran Novus Therapeutics Inc [2017-05-25] 7.7
Peregrine Ventures Management Ltd Novus Therapeutics Inc [2017-05-22] 8.9
OrbiMed Israel BioFund GP Limited Partnership Novus Therapeutics Inc [2017-05-19] 36.2
OTIC Pharma Ltd Tokai Pharmaceuticals Inc [2017-01-05] 39.3
Satter Muneer A Tokai Pharmaceuticals Inc [2015-02-12] 7.9
Novo A/S Tokai Pharmaceuticals Inc [2014-10-22] 5.1
Novartis BioVentures Ltd Tokai Pharmaceuticals Inc [2014-10-01] 21.3
Apple Tree Partners II LP Tokai Pharmaceuticals Inc [2014-09-30] 34.7
Form 3/4/5 Filer 2011 - 2025
Gros David-Alexandre C
Eledon Pharmaceuticals, Inc.
McBride John S.
Hillson Jan
Perrin Steven
Little Paul Sean
Smith Bryan E.
Robinson James A. Jr.
Katkin Keith
Kirk Allan
Lee June
BVF II GP LLC
BVF Partners OS Ltd.
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
Lampert Mark N
BVF I GP LLC
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
BVF Inc/IL
BVF GP Holdings LLC
Lyons Gary A
Ogier Walter C
OrbiMed Israel GP Ltd.
OrbiMed Israel BioFund GP Limited Partnership
Logos Global Management LP
Kuwahara Jon
Turkel Catherine C
Flesher Gregory J
Chimovits Erez
Cohen Cheryl
YOOK Paul
Lifesci Index Partners LLC
Morrison Jodie Pope
Ocampo Christine
Buckley Stephen Jr.
Harrison Seth Loring
Barberich Timothy J
Yanchik Joseph A., III
Kessler David A.
Ferrante Karen Jean
Kalowski Lee
Quirk Gerald E
Novartis Bioventures Ltd
Novartis AG
Satter Muneer A
ATP Life Science Ventures, L.P.
Apple Tree Partners II - Annex, L.P.
Apple Tree Partners II LP
Thomas Robert Bain
Wade Denis Newell
Williams Martin D
Warman Investments Pty. Ltd.
Stewart Susan B.
QBF No. 2 Pty Ltd as trustee for Queensland BioCapital Fund
QBF No. 1 Pty Ltd as trustee for Queensland BioCapital Fund
Platt Jon B.
Form 13F Holdings
Firm Period DFND Voting Shares
BVF Inc/IL [2025-06-30] DFND 0 6,293,282
RA Capital Management LP [2025-06-30] SOLE 3,566,338 3,566,338
Vanguard Group Inc [2025-06-30] SOLE 0 3,269,735
BlackRock, Inc. [2025-06-30] SOLE 3,168,109 3,254,152
First Light Asset Management LLC [2025-06-30] SOLE 2,600,498 2,600,498
Sphera Funds Management Ltd [2025-06-30] DFND 1,959,610 1,990,810
Woodline Partners LP [2025-06-30] SOLE 1,671,822 1,671,822
Geode Capital Management LLC [2025-06-30] DFND 1,383,940 1,383,940
Blue Owl Capital Holdings LP [2025-06-30] DFND 0 1,329,912
Ensign Peak Advisors, Inc [2025-06-30] SOLE 1,264,919 1,264,919
Nantahala Capital Management LLC [2025-06-30] SOLE 1,141,237 1,141,237
AWM Investment Company Inc [2025-06-30] SOLE 1,100,473 1,100,473
Susquehanna International Group LLP [2025-06-30] OTR 1,018,919 1,036,219
Ikarian Capital LLC [2025-06-30] SOLE 1,000,221 1,000,221
Schonfeld Strategic Advisors LLC [2025-06-30] SOLE 998,454 998,454
Zimmer Partners LP [2025-06-30] SOLE 980,682 980,682
Alyeska Investment Group LP [2025-06-30] SOLE 933,475 933,475
Sanofi [2025-06-30] SOLE 814,980 814,980
Siren, L.L.C. [2025-06-30] DFND 690,170 690,170
22NW LP [2025-06-30] SOLE 636,364 636,364
State Street Corp [2025-06-30] DFND 548,807 605,340
Northern Trust Corp [2025-06-30] DFND 445,120 445,120
CM Management LLC [2025-06-30] SOLE 375,000 375,000
Morgan Stanley [2025-06-30] DFND 262,363 345,629
Velan Capital Investment Management LP [2025-06-30] SOLE 338,973 338,973
Boothbay Fund Management LLC [2025-06-30] OTR 0 293,565
Renaissance Technologies LLC [2025-06-30] SOLE 190,673 190,673
Citadel Advisors LLC [2025-06-30] DFND 182,760 182,760
Charles Schwab Investment Management Inc [2025-06-30] SOLE 177,249 177,249
Millennium Management LLC [2025-06-30] SOLE 171,669 171,669
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com